Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Interferon alpha/beta signaling	7/64	9.167620393496858E-5	0.052897169670476876	0	0	7.387256484770208	68.68115344693118	MX2;STAT2;MX1;PTPN6;IFIT1;XAF1;IFIT3
Immune system signaling by interferons, interleukins, prolactin, and growth hormones	14/280	2.7018697928782965E-4	0.07794894352453885	0	0	3.200956937799043	26.300330813056448	IL1RN;STAT2;HGF;MX2;EIF4A3;MX1;NOD2;IFIT1;IFIT3;PTPN6;JAK2;RAF1;XAF1;IL6R
Interferon signaling	9/168	0.002065085607824355	0.33589910682797397	0	0	3.408106219426974	21.070901608568388	MX2;STAT2;EIF4A3;MX1;PTPN6;IFIT1;XAF1;JAK2;IFIT3
Signaling by interleukins	7/109	0.0023285899953412407	0.33589910682797397	0	0	4.1186996270901	24.969584967989775	IL1RN;HGF;PTPN6;NOD2;RAF1;JAK2;IL6R
Inhibition of cellular proliferation by Gleevec	3/24	0.007143874026827108	0.7087388163879399	0	0	8.504761904761905	42.02628153909273	MAP3K1;JAK2;RAF1
Sodium/calcium exchangers	2/9	0.009209762667502333	0.7087388163879399	0	0	16.97022011221407	79.54775740493686	SLC24A4;SLC8B1
SHP2 signaling	4/57	0.014924287331915228	0.7087388163879399	0	0	4.499397832195905	18.918912194265275	JAK2;RAF1;IL6R;GNAI1
Serotonin HTR1 group and FOS pathway	3/32	0.015878755163510054	0.7087388163879399	0	0	6.1561128526645765	25.503379443419295	RPS6KA5;MAP3K1;GNAI1
Natural killer cell receptor signaling pathway	4/60	0.017727332961575918	0.7087388163879399	0	0	4.257707338254451	17.169833259486364	MAP3K1;LCP2;PTPN6;RAF1
EPO receptor signaling	3/34	0.01869717282550638	0.7087388163879399	0	0	5.7583577712609975	22.914710748506117	PTPN6;JAK2;RAF1
MAPK/TRK pathway	3/34	0.01869717282550638	0.7087388163879399	0	0	5.7583577712609975	22.914710748506117	RPS6KA5;RUSC1;RAF1
Adenylate cyclase inhibitory pathway	2/13	0.019098186333203527	0.7087388163879399	0	0	10.797033781928041	42.736407800627916	ADCY4;GNAI1
fMLP induced chemokine gene expression in HMC-1 cells	3/35	0.020203466110130658	0.7087388163879399	0	0	5.578125	21.765292071676836	MAP3K1;NCF1;RAF1
Endothelins	4/64	0.021943857676722512	0.7087388163879399	0	0	3.9730496453900708	15.17414141721777	ADCY4;JAK2;RAF1;GNAI1
T cell receptor/JNK pathway	2/14	0.022039082915071014	0.7087388163879399	0	0	9.896777442094663	37.755591407006726	MAP3K1;LCP2
HIV-1 early elongation complex formation	2/14	0.022039082915071014	0.7087388163879399	0	0	9.896777442094663	37.755591407006726	NELFA;GTF2H3
Interferon gamma signaling regulation	2/14	0.022039082915071014	0.7087388163879399	0	0	9.896777442094663	37.755591407006726	PTPN6;JAK2
TNF-alpha effects on cytokine activity, cell motility, and apoptosis	6/135	0.02563333364589178	0.7087388163879399	0	0	2.7790342080933077	10.18199693951092	IL1RN;HGF;TNFAIP2;TNFRSF10B;LCP2;FLI1
Immune system	25/998	0.027988257899232528	0.7087388163879399	0	0	1.55947598136704	5.576639664282817	IL1RN;CUL7;PHLPP1;NCF1;EIF4A3;NOD2;IFIT1;IFIT3;ASB16;IFIH1;RPS6KA5;JAK2;IL6R;MAP3K1;STAT2;HGF;MX2;CD180;MX1;LILRB3;CAPZA2;LCP2;PTPN6;RAF1;XAF1
Inhibition of platelet activation by aspirin	2/16	0.028435624782609945	0.7087388163879399	0	0	8.48208890807078	30.19719096958858	TBXAS1;RAF1
LPA4-mediated signaling events	2/16	0.028435624782609945	0.7087388163879399	0	0	8.48208890807078	30.19719096958858	RPS6KA5;ADCY4
Other glycan degradation	2/16	0.028435624782609945	0.7087388163879399	0	0	8.48208890807078	30.19719096958858	NEU3;ENGASE
Antiviral mechanism by interferon-stimulated genes	4/70	0.02932985722210078	0.7087388163879399	0	0	3.610758036289951	12.742904066204895	MX2;EIF4A3;MX1;IFIT1
Bioactive peptide-induced signaling pathway	3/41	0.030603052086462294	0.7087388163879399	0	0	4.695933014354067	16.373100829959434	JAK2;RAF1;GNAI1
Platelet sensitization by LDL	2/17	0.031878308849246854	0.7087388163879399	0	0	7.916213494461228	27.27792178055054	PTPN6;LRP8
Leishmaniasis	4/72	0.032081072036307015	0.7087388163879399	0	0	3.504201680672269	12.052663411115974	NCF1;PTPN6;JAK2;FCGR2C
Growth hormone receptor signaling	3/43	0.034585450464847886	0.7087388163879399	0	0	4.460681818181818	15.007170833040426	PTPN6;JAK2;RAF1
Interleukin-3 signaling pathway	3/45	0.0388222259205823	0.7087388163879399	0	0	4.2478354978354975	13.800208091088795	PTPN6;JAK2;RAF1
STAT3 pathway	2/19	0.0392213472789124	0.7087388163879399	0	0	6.984183401457259	22.61851615495576	JAK2;IL6R
Eicosanoid biosynthesis	2/19	0.0392213472789124	0.7087388163879399	0	0	6.984183401457259	22.61851615495576	PTGES2;TBXAS1
MAL role in Rho-mediated activation of SRF	2/19	0.0392213472789124	0.7087388163879399	0	0	6.984183401457259	22.61851615495576	MAP3K1;RAF1
Chemokine signaling pathway	7/189	0.039307493179955084	0.7087388163879399	0	0	2.2988437942425675	7.4398403828163575	NCF1;STAT2;ELMO1;ADCY4;RAF1;JAK2;GNAI1
Signaling by SCF-KIT	4/78	0.04121496002207311	0.7087388163879399	0	0	3.219091431857389	10.265534437475827	PHLPP1;PTPN6;JAK2;RAF1
Regulation of transcription by NOTCH1 intracellular domain	3/47	0.0433101269646307	0.7087388163879399	0	0	4.0543388429752065	12.728064836755625	TLE4;RBPJ;HDAC9
CXCR4 signaling pathway	5/116	0.04471787231665348	0.7087388163879399	0	0	2.685673478356405	8.345413502835036	STAT2;PTPN6;RAF1;JAK2;GNAI1
TRAF6 mediated NF-kB activation	2/22	0.051291402030715354	0.7087388163879399	0	0	5.935649546827794	17.63025707115309	IFIH1;MAP3K1
Differentiation pathway in PC12 cells	4/84	0.05167365798311326	0.7087388163879399	0	0	2.9767477203647417	8.819529412029933	VIPR1;MAP3K1;ADCY4;PLCH1
Nitrogen metabolism	2/23	0.05557364453429488	0.7087388163879399	0	0	5.652711840023018	16.3365984253856	AMT;CA6
Signaling events mediated by stem cell factor receptor (c-Kit)	3/52	0.055601566377088046	0.7087388163879399	0	0	3.6397031539888682	10.51708206779398	PTPN6;JAK2;RAF1
Endometrial cancer	3/52	0.055601566377088046	0.7087388163879399	0	0	3.6397031539888682	10.51708206779398	APC2;AXIN2;RAF1
Kit receptor signaling pathway	3/54	0.060934056360923895	0.7087388163879399	0	0	3.4966131907308378	9.783394482705654	PTPN6;JAK2;RAF1
Basal cell carcinoma	3/55	0.06368669845729633	0.7087388163879399	0	0	3.429195804195804	9.443249291008955	APC2;STK36;AXIN2
Alpha-9 beta-1 integrin pathway	2/25	0.06449436833466345	0.7087388163879399	0	0	5.160646262971233	14.146246759060476	SAT1;PAOX
RNA polymerase I transcription initiation	2/25	0.06449436833466345	0.7087388163879399	0	0	5.160646262971233	14.146246759060476	TAF1C;GTF2H3
TPO signaling pathway	2/25	0.06449436833466345	0.7087388163879399	0	0	5.160646262971233	14.146246759060476	JAK2;RAF1
Interferon alpha signaling regulation	2/25	0.06449436833466345	0.7087388163879399	0	0	5.160646262971233	14.146246759060476	STAT2;PTPN6
PDGFB signaling pathway	5/129	0.06474625302431855	0.7087388163879399	0	0	2.402512785208497	6.57634887153486	DOCK4;TAGLN;RAF1;JAK2;BAIAP2
Neural crest differentiation	4/91	0.06553358158213525	0.7087388163879399	0	0	2.7362610488069037	7.456838284752868	TCF4;AXIN2;RBPJ;HDAC9
ERBB2 role in signal transduction and oncology	2/26	0.06912264435799803	0.7087388163879399	0	0	4.945367573011078	13.213393587611174	RAF1;IL6R
Interleukin-27-mediated signaling events	2/26	0.06912264435799803	0.7087388163879399	0	0	4.945367573011078	13.213393587611174	STAT2;JAK2
Fc gamma receptor-mediated phagocytosis	4/94	0.07200929694132664	0.7087388163879399	0	0	2.6446470786896317	6.957960794822638	NCF1;ASAP2;RAF1;FCGR2C
Arachidonic acid metabolism	3/58	0.07228119453531974	0.7087388163879399	0	0	3.2416528925619836	8.516442234480245	GPX3;PTGES2;TBXAS1
RNA polymerase I, RNA polymerase III, and mitochondrial transcription	4/95	0.07423789722786021	0.7087388163879399	0	0	2.615451417883029	6.801430449829238	TAF1C;SNAPC4;POLRMT;GTF2H3
Transport of inorganic cations/anions and amino acids/oligopeptides	4/95	0.07423789722786021	0.7087388163879399	0	0	2.615451417883029	6.801430449829238	SLC6A6;SLC24A4;SLC12A6;SLC8B1
TRAIL signaling pathway	2/28	0.0786905269657949	0.7087388163879399	0	0	4.564489890773879	11.603994544997297	MAP3K1;TNFRSF10B
Interleukin receptor SHC signaling	2/28	0.0786905269657949	0.7087388163879399	0	0	4.564489890773879	11.603994544997297	PTPN6;JAK2
Interferon-gamma signaling pathway	4/97	0.07879875951523492	0.7087388163879399	0	0	2.5589436872896036	6.501912601926216	MAP3K1;PTGES2;PTPN6;JAK2
Sulfide oxidation to sulfate	1/5	0.08053104659477286	0.7087388163879399	0	0	14.806475903614459	37.299178484216824	TST
Cytochrome P450 metabolism of eicosanoids	1/5	0.08053104659477286	0.7087388163879399	0	0	14.806475903614459	37.299178484216824	TBXAS1
Tachykinin receptors bind tachykinins	1/5	0.08053104659477286	0.7087388163879399	0	0	14.806475903614459	37.299178484216824	TACR1
Leptin signaling pathway	3/61	0.08136376616892242	0.7087388163879399	0	0	3.073510971786834	7.7109018957026985	IL1RN;JAK2;RAF1
Transcription	6/181	0.08268073048882114	0.7087388163879399	0	0	2.0437221494102227	5.094526624091875	TAF1C;SNAPC4;NELFA;POLRMT;SRSF6;GTF2H3
T cell receptor signaling pathway	5/139	0.08306374500314771	0.7087388163879399	0	0	2.222083181652712	5.528869499674485	MAP3K1;LCP2;PTPN6;ASAP2;RAF1
Granule cell survival pathway	4/99	0.08349615671190753	0.7087388163879399	0	0	2.50481522956327	6.219342685725459	VIPR1;MAP3K1;ADCY4;PLCH1
ADP-ribosylation factor	2/29	0.08362072778192667	0.7087388163879399	0	0	4.395210920890679	10.906557011769712	CYTH2;ASAP2
S1P/S1P3 pathway	2/29	0.08362072778192667	0.7087388163879399	0	0	4.395210920890679	10.906557011769712	JAK2;GNAI1
Signaling events mediated by focal adhesion kinase	3/62	0.08449585169250186	0.7087388163879399	0	0	3.0212634822804314	7.465701702901035	ELMO1;RAF1;MAPK8IP3
Colorectal cancer	3/62	0.08449585169250186	0.7087388163879399	0	0	3.0212634822804314	7.465701702901035	APC2;AXIN2;RAF1
PDGFA signaling pathway	2/30	0.08864237594926978	0.7087388163879399	0	0	4.238023305999137	10.269346051206215	MAP3K1;RAF1
Angiotensin II-stimulated signaling through G-proteins and beta-arrestin	3/64	0.09091163930381659	0.7087388163879399	0	0	2.9219076005961253	7.006346516257992	MAP3K1;PLCH1;RAF1
Proteolysis and signaling pathway of Notch	1/6	0.09584400604574611	0.7087388163879399	0	0	11.844578313253011	27.77593111601713	RBPJ
Fas signaling pathway in hepatocytes	1/6	0.09584400604574611	0.7087388163879399	0	0	11.844578313253011	27.77593111601713	NCF1
Influenza factor interactions with host	1/6	0.09584400604574611	0.7087388163879399	0	0	11.844578313253011	27.77593111601713	CPSF4
Thyroid-stimulating hormone signaling pathway	3/66	0.09752360150723163	0.7087388163879399	0	0	2.8288600288600287	6.58462677758445	JAK2;RAF1;GNAI1
ERBB1 downstream pathway	4/106	0.10097966421120727	0.7087388163879399	0	0	2.3320817688777637	5.347081330467241	RPS6KA5;MAP3K1;RAF1;BAIAP2
G alpha i pathway	4/108	0.10626254476611935	0.7087388163879399	0	0	2.2870002338087443	5.127094115283773	MAP3K1;ADCY4;RAF1;GNAI1
CREB phosphorylation	1/7	0.11090269632487465	0.7087388163879399	0	0	9.869979919678714	21.705093290015295	RPS6KA5
Cation-coupled chloride cotransporters	1/7	0.11090269632487465	0.7087388163879399	0	0	9.869979919678714	21.705093290015295	SLC12A6
Gene expression regulation in late stage pancreatic bud precursor cells	1/7	0.11090269632487465	0.7087388163879399	0	0	9.869979919678714	21.705093290015295	RBPJ
MEK activation	1/7	0.11090269632487465	0.7087388163879399	0	0	9.869979919678714	21.705093290015295	RAF1
Negative regulation of the PI3K/Akt network	1/7	0.11090269632487465	0.7087388163879399	0	0	9.869979919678714	21.705093290015295	PHLPP1
CDC42 signaling events	3/70	0.1113065911763065	0.7087388163879399	0	0	2.659430122116689	5.838690546785178	MAP3K1;RAF1;BAIAP2
Rac1 cell motility signaling pathway	3/71	0.11486333022723542	0.7087388163879399	0	0	2.620187165775401	5.670117229288398	MAP3K1;NCF1;BAIAP2
Interleukin-6 signaling pathway	3/71	0.11486333022723542	0.7087388163879399	0	0	2.620187165775401	5.670117229288398	JAK2;RAF1;IL6R
Arf6 signal transduction regulation	2/35	0.1149728233745831	0.7087388163879399	0	0	3.594983063261009	7.776162256642923	CYTH2;HGF
EGF receptor (ErbB1) signaling pathway	2/35	0.1149728233745831	0.7087388163879399	0	0	3.594983063261009	7.776162256642923	PTPN6;GNAI1
Phospholipids as signaling intermediaries	2/36	0.1204550731852808	0.7087388163879399	0	0	3.489070552692376	7.384542573228812	RAF1;GNAI1
GM-CSF-mediated signaling events	2/36	0.1204550731852808	0.7087388163879399	0	0	3.489070552692376	7.384542573228812	JAK2;RAF1
Signaling by NOTCH1	3/73	0.12210332211221507	0.7087388163879399	0	0	2.5450649350649353	5.351985722477037	TLE4;RBPJ;HDAC9
RNA polymerase II C-terminal domain phosphorylation and interaction with capping enzyme	1/8	0.1257113264195534	0.7087388163879399	0	0	8.459552495697073	17.54314131372678	GTF2H3
Cross-presentation of particulate exogenous antigens (phagosomes)	1/8	0.1257113264195534	0.7087388163879399	0	0	8.459552495697073	17.54314131372678	NCF1
Degradation of cysteine and homocysteine	1/8	0.1257113264195534	0.7087388163879399	0	0	8.459552495697073	17.54314131372678	TST
Nef-induced signal transduction	1/8	0.1257113264195534	0.7087388163879399	0	0	8.459552495697073	17.54314131372678	ELMO1
Latent infection of Homo sapiens with Mycobacterium tuberculosis	2/37	0.12600046711126275	0.7087388163879399	0	0	3.389210185584808	7.020646087088026	ATP6V1A;NCF1
Prolactin activation of MAPK signaling	3/75	0.12950557426598297	0.7087388163879399	0	0	2.4741161616161618	5.057171008385173	NEK3;JAK2;RAF1
Signal transduction through IL-1R	2/38	0.1316053995813164	0.7087388163879399	0	0	3.2948976166498825	6.681878497057528	IL1RN;MAP3K1
Signaling of hepatocyte growth factor receptor	2/38	0.1316053995813164	0.7087388163879399	0	0	3.2948976166498825	6.681878497057528	HGF;RAF1
Angiotensin II-mediated activation of JNK pathway via Pyk2-dependent signaling	2/39	0.13726636687622024	0.7087388163879399	0	0	3.2056830244141423	6.36594779408405	MAP3K1;RAF1
Polyadenylation of mRNA	1/9	0.14027403607903927	0.7087388163879399	0	0	7.401731927710843	14.538166309327883	CPSF4
Activation of pro-caspase 8	1/9	0.14027403607903927	0.7087388163879399	0	0	7.401731927710843	14.538166309327883	TNFRSF10B
Pyrimidine salvage reactions	1/9	0.14027403607903927	0.7087388163879399	0	0	7.401731927710843	14.538166309327883	TK2
Benzo(a)pyrene metabolism	1/9	0.14027403607903927	0.7087388163879399	0	0	7.401731927710843	14.538166309327883	AKR1C1
Tat-mediated elongation of the HIV-1 transcript	1/9	0.14027403607903927	0.7087388163879399	0	0	7.401731927710843	14.538166309327883	GTF2H3
Type I hemidesmosome assembly	1/9	0.14027403607903927	0.7087388163879399	0	0	7.401731927710843	14.538166309327883	DST
cAMP receptor, G-protein-independent pathways inferred from amoeba model	1/9	0.14027403607903927	0.7087388163879399	0	0	7.401731927710843	14.538166309327883	STAT2
G alpha s pathway	4/120	0.14043446977375915	0.7087388163879399	0	0	2.049156272927366	4.022523079630029	MAP3K1;ADCY4;PYGM;RAF1
Interleukin-1 regulation of extracellular matrix	4/120	0.14043446977375915	0.7087388163879399	0	0	2.049156272927366	4.022523079630029	IL1RN;SLC25A28;TNFAIP2;PLXDC2
PAC1 receptor pathway	2/40	0.1429799648524762	0.7087388163879399	0	0	3.1211639370329145	6.070822301745592	ADCY4;PLCH1
Signaling events mediated by hepatocyte growth factor receptor (c-Met)	3/79	0.14476584683385607	0.7087388163879399	0	0	2.343421052631579	4.528983852803231	MAP3K1;HGF;RAF1
BDNF signaling pathway	7/261	0.14666980595591425	0.7087388163879399	0	0	1.6411163711897976	3.15024011047302	TAGLN;DOCK4;MAST4;AKR1C1;HGF;ATP10D;ATF3
Nuclear beta-catenin signaling and target gene transcription regulation	3/80	0.14867020036697912	0.7087388163879399	0	0	2.312868949232586	4.408385684231829	TLE4;TCF4;AXIN2
Fc epsilon receptor I signaling in mast cells	2/41	0.14874288652295461	0.7087388163879399	0	0	3.040979161825083	5.7946954426424355	MAP3K1;RAF1
MAP kinase signaling pathway	3/81	0.15260832660578144	0.7087388163879399	0	0	2.283100233100233	4.291955828542387	RPS6KA5;MAP3K1;RAF1
Bladder cancer	2/42	0.15455191984354139	0.7087388163879399	0	0	2.9648036253776433	5.535956007755728	RPS6KA5;RAF1
Signal-dependent regulation of myogenesis by corepressor MITR	1/10	0.1545948968175073	0.7087388163879399	0	0	6.578982597054886	12.282612824708192	HDAC9
Splicing regulation through Sam68	1/10	0.1545948968175073	0.7087388163879399	0	0	6.578982597054886	12.282612824708192	RAF1
Glycoprotein 1b-IX-V activation signaling	1/10	0.1545948968175073	0.7087388163879399	0	0	6.578982597054886	12.282612824708192	RAF1
Interferon-alpha signaling pathway	1/10	0.1545948968175073	0.7087388163879399	0	0	6.578982597054886	12.282612824708192	STAT2
NODAL signaling regulation	1/10	0.1545948968175073	0.7087388163879399	0	0	6.578982597054886	12.282612824708192	ACVR2B
Cell differentiation by G alpha (i/o) pathway inferred from mouse Neuro2A model	2/43	0.16040394547507	0.7087388163879399	0	0	2.892343968756908	5.2931629633388395	RPS6KA5;RAF1
T cell signal transduction	3/83	0.16058202651347098	0.7087388163879399	0	0	2.2257954545454544	4.070869483221833	MAP3K1;LCP2;RAF1
ERBB2/ERBB3 signaling events	2/44	0.1662959345814818	0.7087388163879399	0	0	2.8233347719752553	5.065024012406107	JAK2;RAF1
G-protein-mediated events	2/44	0.1662959345814818	0.7087388163879399	0	0	2.8233347719752553	5.065024012406107	ADCY4;GNAI1
Erythropoietin-mediated neuroprotection through NF-kB	1/11	0.16867791303426824	0.7087388163879399	0	0	5.92078313253012	10.537597988558531	JAK2
Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	1/11	0.16867791303426824	0.7087388163879399	0	0	5.92078313253012	10.537597988558531	GAS6
Amino sugar and nucleotide sugar metabolism	2/45	0.17222494669679514	0.7087388163879399	0	0	2.75753530527647	4.8503772783048005	NAGK;UAP1L1
Wnt interactions in lipid metabolism and immune response	2/45	0.17222494669679514	0.7087388163879399	0	0	2.75753530527647	4.8503772783048005	TCF4;AXIN2
G alpha (z) signaling events	2/45	0.17222494669679514	0.7087388163879399	0	0	2.75753530527647	4.8503772783048005	ADCY4;GNAI1
Interleukin-3, interleukin-5, and GM-CSF signaling	2/45	0.17222494669679514	0.7087388163879399	0	0	2.75753530527647	4.8503772783048005	PTPN6;JAK2
Progesterone-mediated oocyte maturation	3/86	0.17277175156141106	0.7087388163879399	0	0	2.145016429353779	3.766185334923726	ADCY4;RAF1;GNAI1
Phosphatidylethanolamine biosynthesis	1/12	0.1825270230661024	0.7087388163879399	0	0	5.382256297918948	9.154448544065815	PISD
Platelet endothelial cell adhesion molecule 1 (PECAM1) interactions	1/12	0.1825270230661024	0.7087388163879399	0	0	5.382256297918948	9.154448544065815	PTPN6
Reversible hydration of carbon dioxide	1/12	0.1825270230661024	0.7087388163879399	0	0	5.382256297918948	9.154448544065815	CA6
NF-kappaB activation through FADD/RIP-1 pathway	1/12	0.1825270230661024	0.7087388163879399	0	0	5.382256297918948	9.154448544065815	IFIH1
Gap junction pathway	3/90	0.18941247008560624	0.7087388163879399	0	0	2.045977011494253	3.404154371960063	ADCY4;RAF1;GNAI1
Post-translational regulation of adherens junction stability and disassembly	2/48	0.1902059987601046	0.7087388163879399	0	0	2.577301983449363	4.277413025909665	JUP;PTPN6
HES/HEY pathway	2/48	0.1902059987601046	0.7087388163879399	0	0	2.577301983449363	4.277413025909665	RBPJ;JAK2
NGF signaling via TRKA from the plasma membrane	4/136	0.1916824786305746	0.7087388163879399	0	0	1.7992999907893525	2.9722907037563457	RPS6KA5;PHLPP1;ADCY4;RAF1
Adrenergic pathway	4/137	0.1950653848534533	0.7087388163879399	0	0	1.7856800054848367	2.91855195326345	ADCY4;PLCH1;RAF1;GNAI1
Natural killer cell-mediated cytotoxicity	4/137	0.1950653848534533	0.7087388163879399	0	0	1.7856800054848367	2.91855195326345	TNFRSF10B;LCP2;PTPN6;RAF1
Advanced glycosylation endproduct receptor signaling	1/13	0.19614610024014084	0.7087388163879399	0	0	4.933483935742972	8.03612972326308	CAPZA2
Signal regulatory protein (SIRP) family interactions	1/13	0.19614610024014084	0.7087388163879399	0	0	4.933483935742972	8.03612972326308	PTPN6
Death receptor signaling	1/13	0.19614610024014084	0.7087388163879399	0	0	4.933483935742972	8.03612972326308	TNFRSF10B
Interleukin-22 soluble receptor signaling pathway	1/13	0.19614610024014084	0.7087388163879399	0	0	4.933483935742972	8.03612972326308	JAK2
MAP kinase downregulation by phosphorylation of MEK1 by Cdk5/p35	1/13	0.19614610024014084	0.7087388163879399	0	0	4.933483935742972	8.03612972326308	RAF1
Melanocyte development and pigmentation pathway	1/13	0.19614610024014084	0.7087388163879399	0	0	4.933483935742972	8.03612972326308	RAF1
NICD trafficking to the nucleus	1/13	0.19614610024014084	0.7087388163879399	0	0	4.933483935742972	8.03612972326308	RBPJ
PI3K class IB pathway	1/13	0.19614610024014084	0.7087388163879399	0	0	4.933483935742972	8.03612972326308	GNAI1
Arf6 integrin-mediated signaling pathway	2/49	0.19625539387708163	0.7087388163879399	0	0	2.522337211544642	4.107218635088619	ASAP2;MAPK8IP3
Ceramide signaling pathway	2/49	0.19625539387708163	0.7087388163879399	0	0	2.522337211544642	4.107218635088619	MAP3K1;RAF1
G alpha 12 pathway	2/49	0.19625539387708163	0.7087388163879399	0	0	2.522337211544642	4.107218635088619	MAP3K1;RAF1
Interleukin-5 signaling pathway	2/49	0.19625539387708163	0.7087388163879399	0	0	2.522337211544642	4.107218635088619	JAK2;RAF1
p53 signaling pathway	4/139	0.2018860893259472	0.7087388163879399	0	0	1.7590453675560058	2.814563451346483	HGF;TNFRSF10B;ATF3;BCL2L2
Signaling by ERBB4	3/93	0.20215097357813094	0.7087388163879399	0	0	1.9774747474747474	3.161468900842349	PHLPP1;JAK2;RAF1
Type II interferon signaling (interferon-gamma)	2/50	0.20232836386751207	0.7087388163879399	0	0	2.469662638469285	3.946183386445572	STAT2;JAK2
Type I interferon (interferon-alpha/beta) pathway	2/51	0.20842245627068892	0.7087388163879399	0	0	2.419138047968432	3.7936637876618398	STAT2;PTPN6
EGF/EGFR signaling pathway	4/141	0.2087769355868172	0.7087388163879399	0	0	1.7331883832893307	2.7150203481278785	RPS6KA5;MAP3K1;RAF1;JAK2
Polyamine metabolism	1/14	0.20953895400787564	0.7087388163879399	0	0	4.553753475440223	7.116813668729754	PAOX
S1P/S1P4 pathway	1/14	0.20953895400787564	0.7087388163879399	0	0	4.553753475440223	7.116813668729754	GNAI1
T cell receptor/Ras pathway	1/14	0.20953895400787564	0.7087388163879399	0	0	4.553753475440223	7.116813668729754	RAF1
TRAF3-dependent IRF activation pathway	1/14	0.20953895400787564	0.7087388163879399	0	0	4.553753475440223	7.116813668729754	IFIH1
Glycogen breakdown (glycogenolysis)	1/14	0.20953895400787564	0.7087388163879399	0	0	4.553753475440223	7.116813668729754	PYGM
MAP kinase inactivation of SMRT corepressor	1/14	0.20953895400787564	0.7087388163879399	0	0	4.553753475440223	7.116813668729754	MAP3K1
Interleukin-2 receptor beta chain in T cell activation	2/52	0.21453529324624332	0.7087388163879399	0	0	2.3706344410876135	3.6490725931051324	PTPN6;RAF1
Thrombin signaling through protease-activated receptors	2/53	0.22066456986824962	0.7087388163879399	0	0	2.324032936437415	3.5118729288544204	CYTH2;GNAI1
GABA A and B receptor activation	2/53	0.22066456986824962	0.7087388163879399	0	0	2.324032936437415	3.5118729288544204	ADCY4;GNAI1
Prolactin receptor signaling pathway	1/15	0.22270933092767484	0.7087388163879399	0	0	4.228270223752151	6.350387491661809	JAK2
BMP signaling pathway in stem cells	1/15	0.22270933092767484	0.7087388163879399	0	0	4.228270223752151	6.350387491661809	ACVR2B
Calcium signaling by HBx of hepatitis B virus	1/15	0.22270933092767484	0.7087388163879399	0	0	4.228270223752151	6.350387491661809	RAF1
Signaling to p38 via RIT and RIN	1/15	0.22270933092767484	0.7087388163879399	0	0	4.228270223752151	6.350387491661809	RAF1
Eicosanoid ligand-binding G-protein coupled receptors	1/15	0.22270933092767484	0.7087388163879399	0	0	4.228270223752151	6.350387491661809	OXER1
Glycosylation of mammalian N-linked oligosaccarides	1/15	0.22270933092767484	0.7087388163879399	0	0	4.228270223752151	6.350387491661809	B3GALT2
Integrin-mediated cell adhesion	3/100	0.23258514560913657	0.7087388163879399	0	0	1.8341143392689785	2.675053752391593	CAV2;CAPN10;RAF1
RNA polymerase I transcription	2/55	0.2329635760389921	0.7087388163879399	0	0	2.2361055691728895	3.257722194815242	TAF1C;GTF2H3
T cell receptor signaling in naive CD8+ T cells	2/55	0.2329635760389921	0.7087388163879399	0	0	2.2361055691728895	3.257722194815242	LCP2;PTPN6
Transport of mature transcript to cytoplasm	2/55	0.2329635760389921	0.7087388163879399	0	0	2.2361055691728895	3.257722194815242	NXF1;SRSF6
TGF-beta regulation of extracellular matrix	12/565	0.2343223931120707	0.7087388163879399	0	0	1.292119450406449	1.8749394430424529	JUP;B3GALT2;AKR1C1;PUS1;HGF;TNFAIP2;AHR;AXIN2;IFIT1;SAT1;IFIT3;ATF3
Rap1 signaling	1/16	0.23566091568247136	0.7087388163879399	0	0	3.9461847389558233	5.703662724447538	RAF1
Serotonin receptor 2 and ELK-SRF/GATA4 signaling	1/16	0.23566091568247136	0.7087388163879399	0	0	3.9461847389558233	5.703662724447538	RAF1
CD40L signaling pathway	1/16	0.23566091568247136	0.7087388163879399	0	0	3.9461847389558233	5.703662724447538	MAP3K1
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	1/16	0.23566091568247136	0.7087388163879399	0	0	3.9461847389558233	5.703662724447538	NOD2
KIT signaling regulation	1/16	0.23566091568247136	0.7087388163879399	0	0	3.9461847389558233	5.703662724447538	PTPN6
RNA polymerase II transcription	3/101	0.23700118331093437	0.7087388163879399	0	0	1.8153061224489795	2.6134783346231427	NELFA;SRSF6;GTF2H3
GnRH signaling pathway	3/101	0.23700118331093437	0.7087388163879399	0	0	1.8153061224489795	2.6134783346231427	MAP3K1;ADCY4;RAF1
Melanogenesis	3/101	0.23700118331093437	0.7087388163879399	0	0	1.8153061224489795	2.6134783346231427	ADCY4;RAF1;GNAI1
Signaling by ERBB2	3/102	0.24143172001812493	0.7087388163879399	0	0	1.7968778696051424	2.553666368062514	PHLPP1;ADCY4;RAF1
Acute myeloid leukemia	2/57	0.24530242695938553	0.7087388163879399	0	0	2.1545729195276024	3.0277425395368907	JUP;RAF1
Keratinocyte differentiation	2/57	0.24530242695938553	0.7087388163879399	0	0	2.1545729195276024	3.0277425395368907	MAP3K1;RAF1
EGFR1 pathway	4/152	0.24776737537736807	0.7087388163879399	0	0	1.6034666885730715	2.2372609099909337	TAGLN;CAV2;HGF;RAF1
SHC-related events	1/17	0.24839733213454598	0.7087388163879399	0	0	3.699359939759036	5.152193547637034	RAF1
SHC1 events in EGFR signaling	1/17	0.24839733213454598	0.7087388163879399	0	0	3.699359939759036	5.152193547637034	RAF1
Beta-arrestin-dependent recruitment of Src kinases in GPCR signaling	1/17	0.24839733213454598	0.7087388163879399	0	0	3.699359939759036	5.152193547637034	RAF1
SUMOylation by RanBP2 regulates transcriptional repression	1/17	0.24839733213454598	0.7087388163879399	0	0	3.699359939759036	5.152193547637034	HDAC9
Cadmium-induced DNA biosynthesis and proliferation in macrophages	1/17	0.24839733213454598	0.7087388163879399	0	0	3.699359939759036	5.152193547637034	RAF1
TAK1-mediated activation of p38 MAPK	1/17	0.24839733213454598	0.7087388163879399	0	0	3.699359939759036	5.152193547637034	NOD2
G1/S-specific transcription	1/17	0.24839733213454598	0.7087388163879399	0	0	3.699359939759036	5.152193547637034	TK2
Glycosylphosphatidylinositol (GPI) biosynthesis	1/17	0.24839733213454598	0.7087388163879399	0	0	3.699359939759036	5.152193547637034	PIGL
HIV-1 elongation complex formation in the absence of HIV-1 Tat	1/17	0.24839733213454598	0.7087388163879399	0	0	3.699359939759036	5.152193547637034	GTF2H3
NO2-dependent IL-12 pathway in NK cells	1/17	0.24839733213454598	0.7087388163879399	0	0	3.699359939759036	5.152193547637034	JAK2
Osteoclast signaling	1/17	0.24839733213454598	0.7087388163879399	0	0	3.699359939759036	5.152193547637034	TNFRSF11A
Hemostasis pathway	10/468	0.2549475646922851	0.7087388163879399	0	0	1.2984844592858977	1.7746353131849117	DOCK4;HGF;CAPZA2;LCP2;PTPN6;JAK2;GAS6;RAF1;LRP8;GNAI1
Platelet activation, signaling and aggregation	5/205	0.256770410193739	0.7087388163879399	0	0	1.4837652439024391	2.0172870733012656	HGF;LCP2;GAS6;RAF1;GNAI1
Caspase cascade in apoptosis	2/59	0.25766513231288574	0.7087388163879399	0	0	2.0787618593311072	2.818997469955117	MAP3K1;TNFRSF10B
Bone remodeling	1/18	0.26092214429885674	0.7087388163879399	0	0	3.4815733522324592	4.677609435230168	TNFRSF11A
Serotonin receptor 4/6/7 and NR3C signaling	1/18	0.26092214429885674	0.7087388163879399	0	0	3.4815733522324592	4.677609435230168	RPS6KA5
Sodium/chloride-dependent neurotransmitter transporters	1/18	0.26092214429885674	0.7087388163879399	0	0	3.4815733522324592	4.677609435230168	SLC6A6
TNFR2 signaling pathway	1/18	0.26092214429885674	0.7087388163879399	0	0	3.4815733522324592	4.677609435230168	MAP3K1
Human cytomegalovirus and MAP kinase pathways	1/18	0.26092214429885674	0.7087388163879399	0	0	3.4815733522324592	4.677609435230168	MAP3K1
PKA activation in glucagon signaling	1/18	0.26092214429885674	0.7087388163879399	0	0	3.4815733522324592	4.677609435230168	ADCY4
Androgen receptor proteolysis and transcription regulation	2/61	0.27003670841121585	0.7087388163879399	0	0	2.0080905320292897	2.6289868475650353	LATS2;TCF4
HIV genome transcription	2/61	0.27003670841121585	0.7087388163879399	0	0	2.0080905320292897	2.6289868475650353	NELFA;GTF2H3
Apoptosis modulation by HSP70	1/19	0.273238857368733	0.7087388163879399	0	0	3.2879852744310574	4.265861459758775	MAP3K1
Signaling by NODAL	1/19	0.273238857368733	0.7087388163879399	0	0	3.2879852744310574	4.265861459758775	ACVR2B
FRS2-mediated activation	1/19	0.273238857368733	0.7087388163879399	0	0	3.2879852744310574	4.265861459758775	RAF1
Lissencephaly gene (LIS1) in neuronal migration and development	1/19	0.273238857368733	0.7087388163879399	0	0	3.2879852744310574	4.265861459758775	LRP8
Mitochondrial gene expression	1/19	0.273238857368733	0.7087388163879399	0	0	3.2879852744310574	4.265861459758775	POLRMT
Toll receptor cascades	4/159	0.2733513463557499	0.7087388163879399	0	0	1.5305029904892637	1.9850582895612996	RPS6KA5;MAP3K1;CD180;NOD2
Shigellosis	2/62	0.2762214037969852	0.7087388163879399	0	0	1.9745216515609265	2.5403258602685157	ELMO1;NOD2
Cytokine-cytokine receptor interaction	6/265	0.28062355325595084	0.7087388163879399	0	0	1.3749424391626226	1.7471959719834476	HGF;TNFRSF10B;TNFRSF11A;IL6R;ACVR2B;IL17RA
Signaling by EGFR in cancer	3/111	0.28182413627851616	0.7087388163879399	0	0	1.6463804713804713	2.0850948223518757	PHLPP1;ADCY4;RAF1
4-1BB-dependent immune response	1/20	0.2853509186584741	0.7087388163879399	0	0	3.1147748890298033	3.906038480321878	MAP3K1
Signaling by Hippo	1/20	0.2853509186584741	0.7087388163879399	0	0	3.1147748890298033	3.906038480321878	LATS2
Sprouty regulation of tyrosine kinase signals	1/20	0.2853509186584741	0.7087388163879399	0	0	3.1147748890298033	3.906038480321878	RAF1
Dual incision reaction in GG-NER	1/20	0.2853509186584741	0.7087388163879399	0	0	3.1147748890298033	3.906038480321878	GTF2H3
Hypertrophy pathway	1/20	0.2853509186584741	0.7087388163879399	0	0	3.1147748890298033	3.906038480321878	ATF3
Nerve growth factor (NGF) pathway	1/20	0.2853509186584741	0.7087388163879399	0	0	3.1147748890298033	3.906038480321878	RAF1
Interleukin-4 regulation of apoptosis	6/267	0.2863377079872709	0.7087388163879399	0	0	1.3642658792927695	1.7061282176231656	IL1RN;DST;SNAPC4;MX1;GAS6;GNAI1
Validated nuclear estrogen receptor alpha network	2/64	0.2885802743346348	0.7087388163879399	0	0	1.910632491959848	2.374499639964363	AXIN2;APBB1
ERK1/ERK2 MAPK pathway	2/65	0.29475128120916155	0.7087388163879399	0	0	1.880209082626001	2.296907398706934	RPS6KA5;RAF1
LPA receptor mediated events	2/65	0.29475128120916155	0.7087388163879399	0	0	1.880209082626001	2.296907398706934	ADCY4;GNAI1
S1P/S1P1 pathway	1/21	0.2972617184608865	0.7087388163879399	0	0	2.958885542168675	3.589549275014483	GNAI1
E-cadherin keratinocyte pathway	1/21	0.2972617184608865	0.7087388163879399	0	0	2.958885542168675	3.589549275014483	JUP
p38 MK2 pathway	1/21	0.2972617184608865	0.7087388163879399	0	0	2.958885542168675	3.589549275014483	RAF1
IGF1 signaling pathway	1/21	0.2972617184608865	0.7087388163879399	0	0	2.958885542168675	3.589549275014483	RAF1
Nicotine activity on dopaminergic neurons	1/21	0.2972617184608865	0.7087388163879399	0	0	2.958885542168675	3.589549275014483	GNAI1
SIDS susceptibility pathways	2/67	0.30706891583216817	0.7087388163879399	0	0	1.822170578666047	2.1514059620835053	VIPR1;IL6R
T cell receptor signaling in naive CD4+ T cells	2/67	0.30706891583216817	0.7087388163879399	0	0	1.822170578666047	2.1514059620835053	LCP2;PTPN6
RNA polymerase II promoter escape	1/22	0.30897459117970066	0.7087388163879399	0	0	2.8178427997705104	3.3095457581866605	GTF2H3
CCR3 signaling in eosinophils	1/22	0.30897459117970066	0.7087388163879399	0	0	2.8178427997705104	3.3095457581866605	RAF1
Prolactin regulation of apoptosis	3/118	0.3136392784328283	0.7087388163879399	0	0	1.545612648221344	1.7921560238476972	NABP1;TNFRSF11A;TMEM106A
Signaling by NOTCH	3/119	0.3181963099167632	0.7087388163879399	0	0	1.5322100313479623	1.754513420263334	TLE4;RBPJ;HDAC9
Phase I of biological oxidations: functionalization of compounds	2/69	0.31934460985377167	0.7087388163879399	0	0	1.767597060017135	2.01768460667577	TBXAS1;PAOX
NFAT involvement in hypertrophy of the heart	2/69	0.31934460985377167	0.7087388163879399	0	0	1.767597060017135	2.01768460667577	RAF1;HDAC9
BAD phosphorylation mediated by IGF1R signaling	1/23	0.3204928160799339	0.7087388163879399	0	0	2.6896221248630887	3.060508690956803	RAF1
Rho cell motility signaling pathway	1/23	0.3204928160799339	0.7087388163879399	0	0	2.6896221248630887	3.060508690956803	BAIAP2
CREB transcription factor and its extracellular signals	1/23	0.3204928160799339	0.7087388163879399	0	0	2.6896221248630887	3.060508690956803	RPS6KA5
Signaling by bone morphogenetic protein (BMP)	1/23	0.3204928160799339	0.7087388163879399	0	0	2.6896221248630887	3.060508690956803	ACVR2B
Collagen binding in corneal epithelia mediated by Erk and PI-3 Kinase	1/23	0.3204928160799339	0.7087388163879399	0	0	2.6896221248630887	3.060508690956803	RAF1
Deadenylation of mRNA	1/23	0.3204928160799339	0.7087388163879399	0	0	2.6896221248630887	3.060508690956803	EIF4A3
Eicosanoid metabolism	1/23	0.3204928160799339	0.7087388163879399	0	0	2.6896221248630887	3.060508690956803	TBXAS1
Mitochondrial pathway of apoptosis: antiapoptotic Bcl-2 family	1/23	0.3204928160799339	0.7087388163879399	0	0	2.6896221248630887	3.060508690956803	BCL2L2
Modulation of interferon signaling by chaperones	1/23	0.3204928160799339	0.7087388163879399	0	0	2.6896221248630887	3.060508690956803	JAK2
Renal cell carcinoma	2/70	0.3254633744957325	0.7087388163879399	0	0	1.7415141283099342	1.9548589164019319	HGF;RAF1
Signaling events mediated by VEGFR1 and VEGFR2	2/70	0.3254633744957325	0.7087388163879399	0	0	1.7415141283099342	1.9548589164019319	PTPN6;RAF1
Long-term depression	2/70	0.3254633744957325	0.7087388163879399	0	0	1.7415141283099342	1.9548589164019319	RAF1;GNAI1
NCAM signaling for neurite out-growth	2/70	0.3254633744957325	0.7087388163879399	0	0	1.7415141283099342	1.9548589164019319	RPS6KA5;RAF1
RIG-I-like receptor signaling pathway	2/71	0.3315677229005257	0.7087388163879399	0	0	1.7161872236087394	1.8945388881014882	IFIH1;MAP3K1
Bacterial invasion of epithelial cells	2/71	0.3315677229005257	0.7087388163879399	0	0	1.7161872236087394	1.8945388881014882	CAV2;ELMO1
Melanoma	2/71	0.3315677229005257	0.7087388163879399	0	0	1.7161872236087394	1.8945388881014882	HGF;RAF1
Ras-independent pathway in NK cell-mediated cytotoxicity	1/24	0.33181961833015816	0.7087388163879399	0	0	2.57255107386066	2.8379451565908353	PTPN6
Signal transduction of S1P receptor	1/24	0.33181961833015816	0.7087388163879399	0	0	2.57255107386066	2.8379451565908353	GNAI1
Sulfur amino acid metabolism	1/24	0.33181961833015816	0.7087388163879399	0	0	2.57255107386066	2.8379451565908353	TST
TAK1 activates NF-kappaB by phosphorylation and activation of IKK complex	1/24	0.33181961833015816	0.7087388163879399	0	0	2.57255107386066	2.8379451565908353	NOD2
NF-kappaB signaling pathway	1/24	0.33181961833015816	0.7087388163879399	0	0	2.57255107386066	2.8379451565908353	MAP3K1
Signaling by PDGF	3/122	0.33187058640798356	0.7087388163879399	0	0	1.493353705118411	1.6471843480962667	PHLPP1;ADCY4;RAF1
Wnt signaling pathway	5/231	0.3406803640337137	0.7087388163879399	0	0	1.311312864234837	1.4120355792205053	APC2;TLE4;PRICKLE1;AXIN2;HDAC9
SHC1 events in ERBB2 signaling	1/25	0.3429581697313165	0.7087388163879399	0	0	2.4652359437751006	2.6381643401789954	RAF1
Factors involved in megakaryocyte development and platelet production	3/125	0.345536259733099	0.7087388163879399	0	0	1.456408345752608	1.5476635323335766	DOCK4;CAPZA2;JAK2
G alpha (s) signaling events	3/125	0.345536259733099	0.7087388163879399	0	0	1.456408345752608	1.5476635323335766	VIPR1;ADCY4;GNAI1
Interleukin-1 signaling pathway	3/125	0.345536259733099	0.7087388163879399	0	0	1.456408345752608	1.5476635323335766	IL1RN;MAP3K1;NOD2
Adherens junction cell adhesion	2/74	0.34978235003467684	0.7087388163879399	0	0	1.6444276602886876	1.727379456919246	PTPN6;BAIAP2
Seven transmembrane receptor signaling through beta-arrestin	2/74	0.34978235003467684	0.7087388163879399	0	0	1.6444276602886876	1.727379456919246	MAP3K1;RAF1
Gastric acid secretion	2/74	0.34978235003467684	0.7087388163879399	0	0	1.6444276602886876	1.727379456919246	ADCY4;GNAI1
Neurotrophin signaling pathway	3/126	0.35008669956388094	0.7087388163879399	0	0	1.4444937176644495	1.5161036878849272	RPS6KA5;MAP3K1;RAF1
ALK1 pathway	1/26	0.35391158967313313	0.7087388163879399	0	0	2.3665060240963856	2.458109079406321	ACVR2B
Ras signaling pathway	1/26	0.35391158967313313	0.7087388163879399	0	0	2.3665060240963856	2.458109079406321	RAF1
Segmentation clock	1/26	0.35391158967313313	0.7087388163879399	0	0	2.3665060240963856	2.458109079406321	RBPJ
TGF-beta signaling in development	1/26	0.35391158967313313	0.7087388163879399	0	0	2.3665060240963856	2.458109079406321	ACVR2B
Fibroblast growth factor 1	1/26	0.35391158967313313	0.7087388163879399	0	0	2.3665060240963856	2.458109079406321	TCF4
Inhibition of activated T cell apoptosis by neuropeptides VIP and PACAP	1/26	0.35391158967313313	0.7087388163879399	0	0	2.3665060240963856	2.458109079406321	MAP3K1
Spliceosome	3/127	0.35463375662531726	0.7087388163879399	0	0	1.4327712609970675	1.4853105440278567	EIF4A3;PRPF40B;SRSF6
Signaling by FGFR in disease	3/128	0.3591768526486181	0.7087388163879399	0	0	1.4212363636363636	1.455261310824429	PHLPP1;ADCY4;RAF1
RIG-I/MDA5-mediated induction of interferon-alpha/beta pathways	2/76	0.36183225242580663	0.7087388163879399	0	0	1.5998203641708173	1.6263366918155797	IFIH1;MAP3K1
Cell-cell communication	3/129	0.36371541980356076	0.7087388163879399	0	0	1.40988455988456	1.4259340242635787	JUP;DST;PTPN6
ADP signalling through P2Y purinoceptor 12	1/27	0.36468294614051955	0.7087388163879399	0	0	2.2753707136237256	2.2952277455049446	GNAI1
Collecting duct acid secretion	1/27	0.36468294614051955	0.7087388163879399	0	0	2.2753707136237256	2.2952277455049446	ATP6V1A
TNF/stress-related signaling	1/27	0.36468294614051955	0.7087388163879399	0	0	2.2753707136237256	2.2952277455049446	MAP3K1
TWEAK regulation of gene expression	1/27	0.36468294614051955	0.7087388163879399	0	0	2.2753707136237256	2.2952277455049446	BCL2L2
ERK5 role in neuronal survival pathway	1/27	0.36468294614051955	0.7087388163879399	0	0	2.2753707136237256	2.2952277455049446	RAF1
FSH signaling pathway	1/27	0.36468294614051955	0.7087388163879399	0	0	2.2753707136237256	2.2952277455049446	RAF1
Glycosphingolipid biosynthesis: lacto and neolacto series	1/27	0.36468294614051955	0.7087388163879399	0	0	2.2753707136237256	2.2952277455049446	B3GALT2
Transcriptional regulation of white adipocyte differentiation	2/77	0.36782611559700307	0.7087388163879399	0	0	1.5784088620342396	1.578637675201793	MED8;MED18
Mitochondrial pathway of apoptosis: caspases	2/77	0.36782611559700307	0.7087388163879399	0	0	1.5784088620342396	1.578637675201793	CAPN10;XAF1
PTM: gamma carboxylation, hypusine formation and arylsulfatase activation	1/28	0.375275256331205	0.7087388163879399	0	0	2.190986166889781	2.1473756945341016	GAS6
RNA polymerase III transcription initiation From type 3 promoter	1/28	0.375275256331205	0.7087388163879399	0	0	2.190986166889781	2.1473756945341016	SNAPC4
Recycling pathway of cell adhesion molecule L1	1/28	0.375275256331205	0.7087388163879399	0	0	2.190986166889781	2.1473756945341016	RPS6KA5
Dual incision reaction in TC-NER	1/28	0.375275256331205	0.7087388163879399	0	0	2.190986166889781	2.1473756945341016	GTF2H3
G-protein activation	1/28	0.375275256331205	0.7087388163879399	0	0	2.190986166889781	2.1473756945341016	GNAI1
Messenger RNA capping	1/28	0.375275256331205	0.7087388163879399	0	0	2.190986166889781	2.1473756945341016	GTF2H3
Nef in HIV-1 replication and disease pathogenesis	1/28	0.375275256331205	0.7087388163879399	0	0	2.190986166889781	2.1473756945341016	ELMO1
PERK-regulated gene expression	1/28	0.375275256331205	0.7087388163879399	0	0	2.190986166889781	2.1473756945341016	ATF3
Unfolded protein response	2/79	0.37974683784133645	0.7087388163879399	0	0	1.5372542864989995	1.4884471769408958	CUL7;ATF3
Fc epsilon receptor I signaling pathway	2/79	0.37974683784133645	0.7087388163879399	0	0	1.5372542864989995	1.4884471769408958	LCP2;RAF1
Apoptosis modulation and signaling	2/80	0.3856718784505193	0.7087388163879399	0	0	1.517468432876288	1.4457958598351515	TNFRSF10B;BCL2L2
Opioid signaling	2/80	0.3856718784505193	0.7087388163879399	0	0	1.517468432876288	1.4457958598351515	ADCY4;GNAI1
Post-translational modification: biosynthesis of GPI-anchored proteins	1/29	0.38569148760106264	0.7087388163879399	0	0	2.1126290877796903	2.0127386691586358	PIGL
Adherens junction actin cytoskeletal organization	1/29	0.38569148760106264	0.7087388163879399	0	0	2.1126290877796903	2.0127386691586358	JUP
Amine compound SLC transporters	1/29	0.38569148760106264	0.7087388163879399	0	0	2.1126290877796903	2.0127386691586358	SLC6A6
Reelin signaling pathway	1/29	0.38569148760106264	0.7087388163879399	0	0	2.1126290877796903	2.0127386691586358	LRP8
CDO in myogenesis	1/29	0.38569148760106264	0.7087388163879399	0	0	2.1126290877796903	2.0127386691586358	TCF4
Transferrin endocytosis and recycling	1/29	0.38569148760106264	0.7087388163879399	0	0	2.1126290877796903	2.0127386691586358	ATP6V1A
IGF1 pathway	1/29	0.38569148760106264	0.7087388163879399	0	0	2.1126290877796903	2.0127386691586358	RAF1
Influence of Ras and Rho proteins on G1 to S transition	1/29	0.38569148760106264	0.7087388163879399	0	0	2.1126290877796903	2.0127386691586358	RAF1
Inhibition of insulin secretion by adrenaline/noradrenaline	1/29	0.38569148760106264	0.7087388163879399	0	0	2.1126290877796903	2.0127386691586358	GNAI1
Signaling pathway from G-protein families	1/30	0.3959345582632428	0.7142263239904078	0	0	2.03967594515995	1.889772691258717	RAF1
TNFR1 signaling pathway	1/30	0.3959345582632428	0.7142263239904078	0	0	2.03967594515995	1.889772691258717	MAP3K1
TRAF6-mediated IRF7 activation	1/30	0.3959345582632428	0.7142263239904078	0	0	2.03967594515995	1.889772691258717	IFIH1
Tumor necrosis factor (TNF) pathway	1/30	0.3959345582632428	0.7142263239904078	0	0	2.03967594515995	1.889772691258717	MAP3K1
Nuclear events mediated by MAP kinases	1/30	0.3959345582632428	0.7142263239904078	0	0	2.03967594515995	1.889772691258717	RPS6KA5
Platelet homeostasis	2/82	0.3974470426329307	0.7142263239904078	0	0	1.479380664652568	1.365015041419994	PTPN6;LRP8
Response to elevated platelet cytosolic calcium	2/83	0.4032955599212156	0.7142263239904078	0	0	1.461042109581888	1.3267512810291966	HGF;GAS6
Prostaglandin biosynthesis and regulation	1/31	0.4060073384208904	0.7142263239904078	0	0	1.971586345381526	1.7771564743085986	TBXAS1
Alpha-V beta-3 integrin/OPN pathway	1/31	0.4060073384208904	0.7142263239904078	0	0	1.971586345381526	1.7771564743085986	MAP3K1
Amino acid transport across the plasma membrane	1/31	0.4060073384208904	0.7142263239904078	0	0	1.971586345381526	1.7771564743085986	SLC6A6
Signal amplification	1/31	0.4060073384208904	0.7142263239904078	0	0	1.971586345381526	1.7771564743085986	GNAI1
CD40/CD40L signaling	1/31	0.4060073384208904	0.7142263239904078	0	0	1.971586345381526	1.7771564743085986	MAP3K1
One-carbon metabolism	1/31	0.4060073384208904	0.7142263239904078	0	0	1.971586345381526	1.7771564743085986	AMT
PD-1 signaling	1/31	0.4060073384208904	0.7142263239904078	0	0	1.971586345381526	1.7771564743085986	PTPN6
Cell junction organization	2/84	0.4091170189909853	0.717509179203035	0	0	1.4431508363422003	1.289821910310253	DST;JUP
MicroRNAs in cardiomyocyte hypertrophy	2/85	0.41491069886270393	0.7181343204708477	0	0	1.4256906781203362	1.2541686346454894	RAF1;HDAC9
Oncostatin M	6/311	0.41574459437165406	0.7181343204708477	0	0	1.1648067378553166	1.0223324268951304	VIPR1;DNAH17;AKR1C1;HGF;CA6;ATF3
Pancreatic beta-cell development regulation	1/32	0.41591265080681866	0.7181343204708477	0	0	1.9078896230081617	1.6737534366913858	RBPJ
Glycine, serine and threonine metabolism	1/32	0.41591265080681866	0.7181343204708477	0	0	1.9078896230081617	1.6737534366913858	AMT
Netrin-mediated signaling events	1/32	0.41591265080681866	0.7181343204708477	0	0	1.9078896230081617	1.6737534366913858	ELMO1
Jak-STAT signaling pathway	4/199	0.42351543599736813	0.7181343204708477	0	0	1.2140596991660821	1.043077986191655	STAT2;PTPN6;JAK2;IL6R
Syndecan 2 pathway	1/33	0.4256532714055978	0.7181343204708477	0	0	1.8481739457831325	1.578581146851976	CAV2
E2F-mediated regulation of DNA replication	1/33	0.4256532714055978	0.7181343204708477	0	0	1.8481739457831325	1.578581146851976	TK2
Global genomic nucleotide excision repair (GG-NER)	1/33	0.4256532714055978	0.7181343204708477	0	0	1.8481739457831325	1.578581146851976	GTF2H3
Glucagon signaling in metabolic regulation	1/33	0.4256532714055978	0.7181343204708477	0	0	1.8481739457831325	1.578581146851976	ADCY4
Glucagon-type ligand receptors	1/33	0.4256532714055978	0.7181343204708477	0	0	1.8481739457831325	1.578581146851976	VIPR1
Glycoprotein VI-mediated activation cascade	1/33	0.4256532714055978	0.7181343204708477	0	0	1.8481739457831325	1.578581146851976	LCP2
Negative regulators of RIG-I/MDA5 signaling	1/33	0.4256532714055978	0.7181343204708477	0	0	1.8481739457831325	1.578581146851976	IFIH1
Transmembrane transport of small molecules	8/432	0.43050974846878776	0.7237141897992415	0	0	1.117155297532656	0.9415220746920072	ATP6V1A;SLC6A6;SLC24A4;ATP10D;ADCY4;SLC12A6;ABCC10;SLC8B1
TOR signaling	1/34	0.43523193043385927	0.7237141897992415	0	0	1.7920774005111355	1.4907865677355157	ULK2
EGF receptor transactivation by GPCRs in cardiac hypertrophy	1/34	0.43523193043385927	0.7237141897992415	0	0	1.7920774005111355	1.4907865677355157	RAF1
Induction of apoptosis through DR3 and DR4/5 death receptors	1/34	0.43523193043385927	0.7237141897992415	0	0	1.7920774005111355	1.4907865677355157	TNFRSF10B
N-cadherin signaling events	1/34	0.43523193043385927	0.7237141897992415	0	0	1.7920774005111355	1.4907865677355157	JUP
Messenger RNA processing	4/203	0.43835953186982995	0.7247565182874637	0	0	1.1894121061233218	0.980927023595227	CPSF4;NXF1;GTF2H3;SRSF6
Innate immune system	6/319	0.43936503392222115	0.7247565182874637	0	0	1.1345663452237886	0.9330953850462366	IFIH1;RPS6KA5;MAP3K1;CAPZA2;CD180;NOD2
Autophagy regulation	1/35	0.4446513127794838	0.7247565182874637	0	0	1.739280652019844	1.409625868841565	ULK2
Basal transcription factors	1/35	0.4446513127794838	0.7247565182874637	0	0	1.739280652019844	1.409625868841565	GTF2H3
Signal transduction by L1	1/35	0.4446513127794838	0.7247565182874637	0	0	1.739280652019844	1.409625868841565	RPS6KA5
Interleukin-7 signaling pathway	1/35	0.4446513127794838	0.7247565182874637	0	0	1.739280652019844	1.409625868841565	HGF
PIK3C1/AKT pathway	1/35	0.4446513127794838	0.7247565182874637	0	0	1.739280652019844	1.409625868841565	RAF1
Signaling to ERKs	1/36	0.45391405926777917	0.72621679004209	0	0	1.689500860585198	1.3344478546422696	RAF1
Generation of second messenger molecules	1/36	0.45391405926777917	0.72621679004209	0	0	1.689500860585198	1.3344478546422696	LCP2
Glycogen metabolism	1/36	0.45391405926777917	0.72621679004209	0	0	1.689500860585198	1.3344478546422696	PYGM
Ion transport by P-type ATPases	1/36	0.45391405926777917	0.72621679004209	0	0	1.689500860585198	1.3344478546422696	ATP10D
Pathways in cancer	6/325	0.45696649234503434	0.72621679004209	0	0	1.1128814241753184	0.871547758515041	APC2;JUP;STK36;HGF;AXIN2;RAF1
Activation of NMDA receptor upon glutamate binding and postsynaptic events	1/37	0.46302276671322257	0.72621679004209	0	0	1.6424866131191433	1.264680288475352	RAF1
Interleukin-23-mediated signaling events	1/37	0.46302276671322257	0.72621679004209	0	0	1.6424866131191433	1.264680288475352	JAK2
PI3K/AKT activation	1/37	0.46302276671322257	0.72621679004209	0	0	1.6424866131191433	1.264680288475352	PHLPP1
Cell surface interactions at the vascular wall	2/94	0.4656996825271965	0.72621679004209	0	0	1.2856298436884277	0.9824967248161519	PTPN6;GAS6
Antigen-activated B-cell receptor generation of second messengers	4/211	0.4676997879656341	0.72621679004209	0	0	1.1429746119847877	0.8685791739929658	MAP3K1;PTPN6;LILRB3;RAF1
G-protein signaling pathways	2/95	0.47118241870184063	0.72621679004209	0	0	1.2717408959490628	0.9569976895890128	ADCY4;GNAI1
RAC1 activity regulation	1/38	0.47197998933503876	0.72621679004209	0	0	1.5980136763269293	1.199818534697375	ELMO1
Signaling events mediated by HDAC class II	1/38	0.47197998933503876	0.72621679004209	0	0	1.5980136763269293	1.199818534697375	HDAC9
Transport of mature mRNAs derived from intronless transcripts	1/38	0.47197998933503876	0.72621679004209	0	0	1.5980136763269293	1.199818534697375	NXF1
Trefoil factor initiation of mucosal healing	1/38	0.47197998933503876	0.72621679004209	0	0	1.5980136763269293	1.199818534697375	RAF1
EGFR interaction with phospholipase C-gamma	1/38	0.47197998933503876	0.72621679004209	0	0	1.5980136763269293	1.199818534697375	ADCY4
ERBB4 signaling events	1/38	0.47197998933503876	0.72621679004209	0	0	1.5980136763269293	1.199818534697375	JAK2
p38 alpha/beta MAPK downstream pathway	1/38	0.47197998933503876	0.72621679004209	0	0	1.5980136763269293	1.199818534697375	RPS6KA5
Glycosphingolipid metabolism	1/38	0.47197998933503876	0.72621679004209	0	0	1.5980136763269293	1.199818534697375	NEU3
Phagosome	3/154	0.47425822103262266	0.72621679004209	0	0	1.1749548464780253	0.8765202345455535	ATP6V1A;NCF1;FCGR2C
M phase pathway	2/96	0.4766313396156802	0.72621679004209	0	0	1.2581474577360674	0.9323023134211341	GORASP1;PMF1
Integrin signaling pathway	3/155	0.47851323265587803	0.72621679004209	0	0	1.167165071770335	0.8602840098424845	MAP3K1;CAPN10;RAF1
E-cadherin nascent AJ-like junctions pathway	1/39	0.48078823881469396	0.72621679004209	0	0	1.555881420418516	1.1394160854847293	JUP
FAS pathway and stress induction of heat shock protein regulation	1/39	0.48078823881469396	0.72621679004209	0	0	1.555881420418516	1.1394160854847293	MAP3K1
FRS2-mediated cascade	1/39	0.48078823881469396	0.72621679004209	0	0	1.555881420418516	1.1394160854847293	RAF1
GAB1 signalosome	1/39	0.48078823881469396	0.72621679004209	0	0	1.555881420418516	1.1394160854847293	PHLPP1
HIV-1 transcription initiation	1/39	0.48078823881469396	0.72621679004209	0	0	1.555881420418516	1.1394160854847293	GTF2H3
Iron uptake and transport	1/39	0.48078823881469396	0.72621679004209	0	0	1.555881420418516	1.1394160854847293	ATP6V1A
Nuclear signaling by ErbB4	1/40	0.4894499856652284	0.7373698217463102	0	0	1.5159097930182268	1.0830766123357287	JAK2
Senescence and autophagy	2/99	0.49277136126105486	0.7404403006448663	0	0	1.2190488055564208	0.8627330091830576	RAF1;IL6R
Plasma membrane estrogen receptor signaling	1/41	0.4979676592377845	0.743410395405473	0	0	1.4779367469879519	1.0304472735616923	GNAI1
ERBB1 internalization pathway	1/41	0.4979676592377845	0.743410395405473	0	0	1.4779367469879519	1.0304472735616923	RAF1
TNF-alpha signaling pathway	2/101	0.5033556243898232	0.743410395405473	0	0	1.194299490371998	0.819836859901115	MAP3K1;RAF1
Signaling by NGF	4/221	0.5035641013888826	0.743410395405473	0	0	1.0897426918605466	0.7476117222571171	RPS6KA5;PHLPP1;ADCY4;RAF1
Signaling events mediated by T cell protein tyrosine phosphatase (TC-PTP)	1/42	0.5063436488636931	0.743410395405473	0	0	1.4418160446664707	0.9812130473318631	HGF
TWEAK signaling pathway	1/42	0.5063436488636931	0.743410395405473	0	0	1.4418160446664707	0.9812130473318631	RAF1
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling	1/42	0.5063436488636931	0.743410395405473	0	0	1.4418160446664707	0.9812130473318631	HGF
Eukaryotic transcription initiation	1/42	0.5063436488636931	0.743410395405473	0	0	1.4418160446664707	0.9812130473318631	GTF2H3
Messenger RNA splicing: minor pathway	1/42	0.5063436488636931	0.743410395405473	0	0	1.4418160446664707	0.9812130473318631	SRSF6
Cleavage of growing transcript in the termination region	1/43	0.5145803043424995	0.75167806482436	0	0	1.4074153757888697	0.935091917791827	SRSF6
PI3K class IB pathway in neutrophils	1/43	0.5145803043424995	0.75167806482436	0	0	1.4074153757888697	0.935091917791827	NCF1
Interleukin-4 signaling pathway	2/104	0.5189623854270168	0.7539658085752766	0	0	1.1589953201824537	0.7602126998231842	PTPN6;JAK2
Actin cytoskeleton regulation	4/226	0.5210972745448534	0.7539658085752766	0	0	1.064925107478299	0.694137936514953	APC2;TMSB4XP8;RAF1;BAIAP2
Gastrin pathway	1/44	0.5226799366206424	0.7539658085752766	0	0	1.374614738021855	0.8918307673451705	HGF
HNF3A pathway	1/44	0.5226799366206424	0.7539658085752766	0	0	1.374614738021855	0.8918307673451705	PISD
PI3K events in ERBB2 signaling	1/44	0.5226799366206424	0.7539658085752766	0	0	1.374614738021855	0.8918307673451705	PHLPP1
Fibroblast growth factor receptor pathway	2/105	0.5240917105021827	0.7541169998996494	0	0	1.1476842753644443	0.7415057151584703	RPS6KA5;RAF1
RNA polymerase III transcription	1/45	0.5306448184797996	0.7597569733569339	0	0	1.3433050383351588	0.8512018586571478	SNAPC4
Interleukin-12/STAT4 pathway	1/45	0.5306448184797996	0.7597569733569339	0	0	1.3433050383351588	0.8512018586571478	JAK2
Polo-like kinase 1 (PLK1) pathway	1/46	0.5384771850222738	0.7671637919946963	0	0	1.3133868808567604	0.8129998113484773	GORASP1
Syndecan 1 pathway	1/46	0.5384771850222738	0.7671637919946963	0	0	1.3133868808567604	0.8129998113484773	HGF
Signaling by insulin receptor	2/109	0.5442387254193081	0.7705266950201967	0	0	1.1045543100770816	0.6719747176851862	ATP6V1A;RAF1
ABC transporters	1/47	0.5461792344250614	0.7705266950201967	0	0	1.2847695128339445	0.7770389937696361	ABCC10
Regulation of NFAT transcription factors	1/47	0.5461792344250614	0.7705266950201967	0	0	1.2847695128339445	0.7770389937696361	TLE4
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	1/47	0.5461792344250614	0.7705266950201967	0	0	1.2847695128339445	0.7770389937696361	NOD2
Developmental biology	7/420	0.552048772257589	0.7741128207995489	0	0	1.001039825309348	0.5947366609183491	RPS6KA5;MED8;TCF4;RBPJ;RAF1;ACVR2B;MED18
Activation of chaperones by IRE1 alpha	1/48	0.5537531285043358	0.7741128207995489	0	0	1.257369905152525	0.7431512664933358	CUL7
Presenilin action in Notch and Wnt signaling	1/48	0.5537531285043358	0.7741128207995489	0	0	1.257369905152525	0.7431512664933358	RBPJ
Epidermal growth factor receptor (EGFR) pathway	2/111	0.5540876862915316	0.7741128207995489	0	0	1.08417639069819	0.640132788430687	RPS6KA5;RAF1
Lipid metabolism regulation by peroxisome proliferator-activated receptor alpha (PPAR-alpha)	2/112	0.5589555459726679	0.7783965701983051	0	0	1.0742653117275474	0.6248843757849976	MED8;MED18
Amino acid and oligopeptide SLC transporters	1/49	0.5612009934185354	0.7783965701983051	0	0	1.2311119477911647	0.7111840232527163	SLC6A6
Deadenylation-dependent mRNA decay	1/49	0.5612009934185354	0.7783965701983051	0	0	1.2311119477911647	0.7111840232527163	EIF4A3
mTOR signaling pathway	2/113	0.5637855135178877	0.7801060942441757	0	0	1.0645328107563756	0.610063948206935	ULK2;RAF1
Aquaporin-mediated transport	1/50	0.5685249199750587	0.7847820067598298	0	0	1.2059257437914925	0.6809984861317812	ADCY4
Disease	11/674	0.5699790960812938	0.7849115475868892	0	0	0.9791930149986416	0.550458829388799	ATP6V1A;CPSF4;CUL7;PHLPP1;NCF1;ADCY4;ELMO1;NELFA;GTF2H3;RAF1;ATF3
Fas signaling pathway	2/115	0.5733314211215029	0.7871906599979928	0	0	1.0455845787771034	0.5816496391982879	MAP3K1;PTPN6
Glutathione metabolism	1/51	0.5757269645045978	0.7871906599979928	0	0	1.1817469879518072	0.6524682157855655	GPX3
Malaria	1/51	0.5757269645045978	0.7871906599979928	0	0	1.1817469879518072	0.6524682157855655	HGF
Vascular smooth muscle contraction	2/116	0.5780472188783705	0.787543042526943	0	0	1.0363597816292998	0.5680285062186841	ADCY4;RAF1
Leukocyte transendothelial migration	2/117	0.5827248391079033	0.787543042526943	0	0	1.0272954157362406	0.554780799308798	NCF1;GNAI1
Signaling events mediated by PTP1B	1/52	0.582809149322365	0.787543042526943	0	0	1.158516418615639	0.6254778078969256	JAK2
Taste transduction	1/52	0.582809149322365	0.787543042526943	0	0	1.158516418615639	0.6254778078969256	ADCY4
Drug metabolism: other enzymes	1/52	0.582809149322365	0.787543042526943	0	0	1.158516418615639	0.6254778078969256	TK2
HIV life cycle	2/118	0.5873642421663074	0.7884106937136419	0	0	1.0183873320137515	0.5418942225837723	NELFA;GTF2H3
Starch and sucrose metabolism	1/53	0.589773463333976	0.7884106937136419	0	0	1.1361793327154772	0.599921748519286	PYGM
JNK/MAPK pathway	1/53	0.589773463333976	0.7884106937136419	0	0	1.1361793327154772	0.599921748519286	MAP3K1
PI3K pathway	1/53	0.589773463333976	0.7884106937136419	0	0	1.1361793327154772	0.599921748519286	RPS6KA5
Phospholipase C-mediated cascade	1/54	0.5966218623909754	0.7884106937136419	0	0	1.1146851557172084	0.5757034071170539	ADCY4
RANKL signaling pathway	1/54	0.5966218623909754	0.7884106937136419	0	0	1.1146851557172084	0.5757034071170539	TNFRSF11A
Arginine and proline metabolism	1/54	0.5966218623909754	0.7884106937136419	0	0	1.1146851557172084	0.5757034071170539	SAT1
Non-small cell lung cancer	1/54	0.5966218623909754	0.7884106937136419	0	0	1.1146851557172084	0.5757034071170539	RAF1
TGF-beta signaling pathway	3/185	0.5976094589190061	0.7884106937136419	0	0	0.9732767232767233	0.5010601981223404	RAF1;HDAC9;ATF3
Notch signaling pathway	2/121	0.6010529270478557	0.7884106937136419	0	0	0.9925613750031734	0.5052854855408068	RBPJ;JAK2
Generic transcription pathway	6/377	0.6012173618242553	0.7884106937136419	0	0	0.9543262691955785	0.48556000608675615	ZNF528;MED8;RBPJ;ZNF555;ZNF169;ZNF543
Calcineurin-dependent NFAT signaling role in lymphocytes	1/55	0.6033562701585728	0.7884106937136419	0	0	1.093987059348505	0.5527341472086131	MAP3K1
TAp63 pathway	1/55	0.6033562701585728	0.7884106937136419	0	0	1.093987059348505	0.5527341472086131	DST
Vibrio cholerae infection	1/55	0.6033562701585728	0.7884106937136419	0	0	1.093987059348505	0.5527341472086131	ATP6V1A
SLC-mediated transmembrane transport	4/251	0.6039471865189423	0.7884106937136419	0	0	0.9559085930866446	0.48203461570526146	SLC6A6;SLC24A4;SLC12A6;SLC8B1
Steroid hormone biosynthesis	1/56	0.60997857837473	0.7944867713819846	0	0	1.074041621029573	0.5309325409822548	AKR1C1
Transmission across chemical synapses	3/190	0.6156597427091465	0.7975674968285893	0	0	0.9470102090422946	0.45935756160633545	ADCY4;RAF1;GNAI1
Pre-NOTCH expression and processing	1/57	0.6164906474619598	0.7975674968285893	0	0	1.0548085197934596	0.5102236725507501	RBPJ
PI3K cascade	1/57	0.6164906474619598	0.7975674968285893	0	0	1.0548085197934596	0.5102236725507501	PHLPP1
Integration of energy metabolism	2/125	0.6187690461561514	0.7987242497362401	0	0	0.960086458870631	0.4608637588125738	ADCY4;GNAI1
HIV-1 Nef as negative effector of Fas and TNF	1/58	0.6228943071084218	0.8004677398698427	0	0	1.0362502642147537	0.4905385191181255	MAP3K1
Nucleotide excision repair	1/58	0.6228943071084218	0.8004677398698427	0	0	1.0362502642147537	0.4905385191181255	GTF2H3
ATF2 transcription factor network	1/59	0.6291913567665298	0.8067631396761948	0	0	1.0183319484835895	0.4718134002796654	ATF3
RAGE pathway	1/60	0.6353835659286644	0.8110980476567243	0	0	1.001021033285685	0.4539894871885432	TRMT1
Neurotrophic factor-mediated Trk receptor signaling	1/60	0.6353835659286644	0.8110980476567243	0	0	1.001021033285685	0.4539894871885432	ELMO1
FGF signaling pathway	1/61	0.6414726750276565	0.8134719417383687	0	0	0.9842871485943775	0.4370123629381898	HGF
Glucose metabolism	1/61	0.6414726750276565	0.8134719417383687	0	0	0.9842871485943775	0.4370123629381898	PYGM
Ion channel transport	1/61	0.6414726750276565	0.8134719417383687	0	0	0.9842871485943775	0.4370123629381898	ATP10D
G alpha (i) signaling events	3/199	0.6467540578256935	0.8183708143978622	0	0	0.9031076066790352	0.3935645267585128	ADCY4;OXER1;GNAI1
HIV infection	3/200	0.6500969713560921	0.8208007712745409	0	0	0.8984771573604061	0.3869145790440944	ELMO1;NELFA;GTF2H3
Adipogenesis	2/133	0.6523754442910641	0.8218791077640698	0	0	0.9010862295611264	0.38488550989994336	STAT2;AHR
MAPK cascade role in angiogenesis	1/64	0.6591383757978295	0.8265655432050687	0	0	0.9372729011283228	0.3906757665607807	RAF1
Ubiquitin-mediated proteolysis	2/136	0.6643568485284678	0.8265655432050687	0	0	0.8807773819723137	0.3601814485755743	CUL7;MAP3K1
Oxidative phosphorylation	2/136	0.6643568485284678	0.8265655432050687	0	0	0.8807773819723137	0.3601814485755743	ATP6V1A;NDUFS7
Glioma	1/65	0.6648319187695025	0.8265655432050687	0	0	0.9225809487951807	0.3766169396437152	RAF1
Interleukin-12-mediated signaling events	1/65	0.6648319187695025	0.8265655432050687	0	0	0.9225809487951807	0.3766169396437152	JAK2
Diabetes pathways	2/137	0.6682762610266867	0.8265655432050687	0	0	0.8742083473201298	0.3523528447288421	CUL7;ATF3
Gastrin-CREB signaling pathway via PKC and MAPK	3/206	0.6696812624975121	0.8265655432050687	0	0	0.8716524854455889	0.3494920341142435	F2RL1;TACR1;RAF1
Retinoblastoma protein regulation	1/66	0.6704306406893621	0.8265655432050687	0	0	0.9083410565338276	0.36318656975000907	RAF1
Capped intron-containing pre-mRNA processing	2/138	0.6721586987961581	0.8265655432050687	0	0	0.8677359161187134	0.34471747066227776	NXF1;SRSF6
Adipocytokine signaling pathway	1/67	0.6759361158589042	0.8265655432050687	0	0	0.8945326761591822	0.35034972544383447	JAK2
cAMP cell motility pathway inferred from amoeba model	1/67	0.6759361158589042	0.8265655432050687	0	0	0.8945326761591822	0.35034972544383447	PLCH1
G alpha 13 pathway	1/67	0.6759361158589042	0.8265655432050687	0	0	0.8945326761591822	0.35034972544383447	MAP3K1
Biological oxidations	2/139	0.6760043024060199	0.8265655432050687	0	0	0.8613579729640329	0.33726974331252163	TBXAS1;PAOX
Insulin signaling pathway	4/277	0.6802698624001566	0.8265655432050687	0	0	0.8637117694868455	0.33275852211934115	RPS6KA5;MAP3K1;PYGM;RAF1
CD8/T cell receptor downstream pathway	1/68	0.6813498929288442	0.8265655432050687	0	0	0.8811364862434814	0.3380738407600099	RAF1
Epithelial cell signaling in Helicobacter pylori infection	1/68	0.6813498929288442	0.8265655432050687	0	0	0.8811364862434814	0.3380738407600099	ATP6V1A
Messenger RNA splicing: major pathway	1/68	0.6813498929288442	0.8265655432050687	0	0	0.8811364862434814	0.3380738407600099	SRSF6
Toll-like receptor signaling pathway regulation	2/142	0.6873215966497109	0.8265655432050687	0	0	0.8427708243418213	0.3159994311157151	CD180;PTPN6
Pancreatic cancer	1/70	0.6919084183155081	0.8265655432050687	0	0	0.855508992491706	0.31508539542328506	RAF1
AP-1 transcription factor network	1/70	0.6919084183155081	0.8265655432050687	0	0	0.855508992491706	0.31508539542328506	ATF3
Signaling events mediated by HDAC class I	1/70	0.6919084183155081	0.8265655432050687	0	0	0.855508992491706	0.31508539542328506	HDAC9
Hedgehog signaling pathway	1/70	0.6919084183155081	0.8265655432050687	0	0	0.855508992491706	0.31508539542328506	STK36
Long-term potentiation	1/70	0.6919084183155081	0.8265655432050687	0	0	0.855508992491706	0.31508539542328506	RAF1
MicroRNA regulation of DNA damage response	1/70	0.6919084183155081	0.8265655432050687	0	0	0.855508992491706	0.31508539542328506	TNFRSF10B
Nucleotide metabolism	1/70	0.6919084183155081	0.8265655432050687	0	0	0.855508992491706	0.31508539542328506	TK2
Interleukin-5 regulation of apoptosis	2/144	0.6946851072264292	0.8281679894001025	0	0	0.8308157099697885	0.30266335433516256	LCP2;RAF1
Mitochondrial pathway of apoptosis: multidomain Bcl-2 family	1/71	0.6970561370350717	0.8292812186994565	0	0	0.8432444061962134	0.30431790922111596	CAPN10
Sphingolipid metabolism	1/72	0.7021180990676689	0.8301683261517314	0	0	0.8313253012048193	0.29400123277446777	NEU3
Costimulation by the CD28 family	1/72	0.7021180990676689	0.8301683261517314	0	0	0.8313253012048193	0.29400123277446777	PTPN6
Myocyte adrenergic pathway	1/72	0.7021180990676689	0.8301683261517314	0	0	0.8313253012048193	0.29400123277446777	GNAI1
Chronic myeloid leukemia	1/73	0.7070957287199041	0.8343440398187825	0	0	0.8197372824631861	0.28411210611287735	RAF1
RANKL regulation of apoptosis and immune response	1/74	0.7119904269649369	0.8355582731767216	0	0	0.808466743687077	0.27462872539358324	TNFRSF11A
Wnt/calcium/cyclic GMP pathway	1/74	0.7119904269649369	0.8355582731767216	0	0	0.808466743687077	0.27462872539358324	PLCH1
Calcium regulation in the cardiac cell	2/149	0.7124690994851768	0.8355582731767216	0	0	0.802351151941139	0.2720120741001292	ADCY4;GNAI1
Arrhythmogenic right ventricular cardiomyopathy (ARVC)	1/75	0.7168035712694892	0.8389364312829519	0	0	0.7975008140670792	0.2655306355339168	JUP
VEGF signaling pathway	1/76	0.7215365165765786	0.8427663361633316	0	0	0.7868273092369478	0.2567986307684606	RAF1
Peroxisome	1/78	0.7307671172274403	0.850198944644746	0	0	0.7663120012517602	0.24036176797628112	PAOX
Myometrial relaxation and contraction pathways	2/155	0.7326583947171675	0.850198944644746	0	0	0.7706494480974666	0.23973033420436485	ADCY4;ATF3
Antigen processing: cross presentation	1/79	0.7352673715385238	0.850198944644746	0	0	0.7564488724127278	0.2326239705155133	NCF1
p73 transcription factor network	1/79	0.7352673715385238	0.850198944644746	0	0	0.7564488724127278	0.2326239705155133	GRAMD4
Glycerophospholipid metabolism	1/79	0.7352673715385238	0.850198944644746	0	0	0.7564488724127278	0.2326239705155133	PISD
Gene expression	14/968	0.7431678850998655	0.8550147047707609	0	0	0.8608597359410632	0.2555318397590547	EIF4A3;MED8;RBPJ;GTF2H3;POLRMT;NXF1;TAF1C;ZNF528;SNAPC4;NELFA;SRSF6;ZNF555;ZNF169;ZNF543
Respiratory electron transport, ATP biosynthesis by chemiosmotic coupling, and heat production by uncoupling proteins	1/81	0.7440441245608829	0.8550147047707609	0	0	0.7374623493975904	0.21803438570629566	NDUFS7
Focal adhesion	3/233	0.7478484976685923	0.8550147047707609	0	0	0.7682608695652174	0.22322193304625504	CAV2;HGF;RAF1
ATM-dependent DNA damage response	1/82	0.7483230951633176	0.8550147047707609	0	0	0.7283206901680798	0.21115506141026158	MAP3K1
Regular glucocorticoid receptor pathway	1/82	0.7483230951633176	0.8550147047707609	0	0	0.7283206901680798	0.21115506141026158	VIPR1
SMAD2/3 nuclear pathway	1/82	0.7483230951633176	0.8550147047707609	0	0	0.7283206901680798	0.21115506141026158	ATF3
Drug metabolism: cytochrome P450	1/83	0.7525307421687611	0.8581230004572633	0	0	0.7194019982368498	0.20453564953316639	AKR1C1
TGF-beta regulation of skeletal system development	1/85	0.7607367876089381	0.8640652095479474	0	0	0.7022016637980494	0.19202958484208454	ACVR2B
NOD signaling pathway	1/85	0.7607367876089381	0.8640652095479474	0	0	0.7022016637980494	0.19202958484208454	NOD2
Glycerophospholipid biosynthesis	1/86	0.7647374979735926	0.8647691183322517	0	0	0.693905031892275	0.1861210423011421	PISD
Mitotic G2-G2/M phases	1/87	0.7686715096835861	0.8647691183322517	0	0	0.6858013449145419	0.18042855000332028	CEP131
MAPK signaling pathway	4/314	0.7701724332563543	0.8647691183322517	0	0	0.7591724678890087	0.19825094349364433	RPS6KA5;MAP3K1;RAF1;MAPK8IP3
Apoptosis	3/242	0.7703870174473204	0.8647691183322517	0	0	0.7389882084442754	0.19277414181229738	MAP3K1;TNFRSF10B;BCL2L2
Androgen receptor signaling, proteolysis, and transcription regulation	1/88	0.7725399313011585	0.8647691183322517	0	0	0.6778839495914694	0.17494258229474063	GAS6
HIF-1 degradation in normoxia	1/88	0.7725399313011585	0.8647691183322517	0	0	0.6778839495914694	0.17494258229474063	HDAC9
Hematopoietic cell lineage	1/88	0.7725399313011585	0.8647691183322517	0	0	0.6778839495914694	0.17494258229474063	IL6R
Alzheimer's disease	2/169	0.7751227604012221	0.8647691183322517	0	0	0.7055375653526783	0.1797243085650404	NDUFS7;APBB1
Prostate cancer	1/89	0.7763438531994911	0.8647691183322517	0	0	0.6701464950711938	0.16965411724562368	RAF1
Salivary secretion	1/89	0.7763438531994911	0.8647691183322517	0	0	0.6701464950711938	0.16965411724562368	ADCY4
Thymic stromal lymphopoietin (TSLP) pathway	1/90	0.7800843475734742	0.8672614037570223	0	0	0.6625829159333965	0.16455460547970296	TNFRSF11A
Fatty acid, triacylglycerol, and ketone body metabolism	2/173	0.7861252117813733	0.8722966292266392	0	0	0.6888924223953641	0.165774519151301	MED8;MED18
Metapathway biotransformation	2/174	0.7888009895849755	0.8729610057146397	0	0	0.6848521042647369	0.16247514952267436	AKR1C1;NAT9
T cell receptor regulation of apoptosis	8/603	0.7897498179948734	0.8729610057146397	0	0	0.789016160310278	0.18623864050456282	IL1RN;VIPR1;TAF1C;PRUNE2;MX1;TNFRSF10B;ATF3;GNAI1
Adaptive immune system	8/606	0.7941882111800486	0.8731195644510384	0	0	0.784934396706972	0.18087620388667386	CUL7;PHLPP1;NCF1;LCP2;PTPN6;LILRB3;RAF1;ASB16
ERBB signaling pathway	1/94	0.7944328792665428	0.8731195644510384	0	0	0.6339551755408732	0.145890062135642	RAF1
L1CAM interactions	1/94	0.7944328792665428	0.8731195644510384	0	0	0.6339551755408732	0.145890062135642	RPS6KA5
Class B GPCRs (secretin family receptors)	1/95	0.7978717079534277	0.8739566817181881	0	0	0.627178928479877	0.14162168170392017	VIPR1
Calcium signaling pathway	2/178	0.799211818443842	0.8739566817181881	0	0	0.6691499588025268	0.14997608771481974	ADCY4;TACR1
Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins	3/255	0.8000168754610635	0.8739566817181881	0	0	0.7003968253968254	0.15627426070487696	CUL7;NCF1;ASB16
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	1/96	0.8012531795995174	0.8739566817181881	0	0	0.6205453392517438	0.13749938286850893	SLC6A6
TSH regulation of gene expression	1/97	0.8045782479175789	0.8742780584716442	0	0	0.6140499497991968	0.13351721239140427	AHR
Mitochondrial pathway of apoptosis: BH3-only Bcl-2 family	1/97	0.8045782479175789	0.8742780584716442	0	0	0.6140499497991968	0.13351721239140427	CAPN10
Downstream signaling events Of B cell receptor (BCR)	1/98	0.8078478509604784	0.8745369793699739	0	0	0.6076884859023723	0.12966950584877193	PHLPP1
Wnt signaling pathway and pluripotency	1/98	0.8078478509604784	0.8745369793699739	0	0	0.6076884859023723	0.12966950584877193	AXIN2
Pyrimidine metabolism	1/100	0.8142243358846519	0.8781447510382134	0	0	0.5953511013751978	0.12235617378136959	TK2
Dilated cardiomyopathy	1/100	0.8142243358846519	0.8781447510382134	0	0	0.5953511013751978	0.12235617378136959	ADCY4
Pancreatic secretion	1/101	0.8173330170155472	0.8798528933171096	0	0	0.589367469879518	0.1188805211861559	ADCY4
Chagas disease	1/104	0.8263513002471543	0.8877210691679425	0	0	0.5721136975084805	0.1091222736744902	GNAI1
DNA repair	1/105	0.8292576365364316	0.8877210691679425	0	0	0.5665836422613532	0.10607827806968187	GTF2H3
Electron transport chain	1/105	0.8292576365364316	0.8877210691679425	0	0	0.5665836422613532	0.10607827806968187	NDUFS7
Peptide G-protein coupled receptors	2/192	0.8321555606642479	0.8891736268579092	0	0	0.6193989505485769	0.11380581353309027	F2RL1;TACR1
Neuroactive ligand-receptor interaction	3/272	0.8338778123115951	0.8893669088794646	0	0	0.655559310577898	0.1190944080267515	VIPR1;F2RL1;TACR1
Amino acid metabolism	2/195	0.8385498161960218	0.8926997120758385	0	0	0.609677065886073	0.10735272326741527	TST;PAOX
Post-translational protein modification	2/196	0.8406318669638231	0.8932681164606371	0	0	0.6065032547419565	0.10528984284350654	PIGL;GAS6
Leptin influence on immune response	1/110	0.8430777581561315	0.8942203427501615	0	0	0.5404553995799712	0.09225362105699589	IL1RN
Endocytosis	2/201	0.8506821812495368	0.8991355634340773	0	0	0.59111266301295	0.09559278044566995	CAV2;ASAP2
Oocyte meiosis	1/113	0.8508284534402187	0.8991355634340773	0	0	0.5258982358003442	0.08495610063475725	ADCY4
Neuronal system	3/283	0.8530676274940473	0.899853786223154	0	0	0.629448051948052	0.10002965157073976	ADCY4;RAF1;GNAI1
Phospholipid metabolism	2/205	0.858304091537955	0.9036252240681437	0	0	0.5793460628339262	0.08852223795986276	NEU3;PISD
Tricarboxylic acid (TCA) cycle and respiratory electron transport	1/117	0.8605721718495104	0.9036252240681437	0	0	0.5076599501454092	0.07622909865010673	NDUFS7
DNA replication	2/207	0.8619805161556908	0.9036252240681437	0	0	0.5736349568933756	0.08519776192668704	GORASP1;PMF1
p53 activity regulation	1/118	0.8629072763631667	0.9036252240681437	0	0	0.5032952322108949	0.07420989404664327	TNFRSF10B
Immunoregulatory interactions between a lymphoid and a non-lymphoid cell	1/119	0.865203387948966	0.9043883239973795	0	0	0.499004492546457	0.0722511943658353	LILRB3
Lysosome	1/121	0.8696812183138589	0.9074250686565943	0	0	0.4906375502008032	0.06850700981378721	CLN3
Influenza viral RNA transcription and replication	1/125	0.8781968166910465	0.9146562513190141	0	0	0.47471336960746213	0.0616579303358959	EIF4A3
HIV factor interactions with host	1/128	0.8842173531048638	0.9192674103450567	0	0	0.4634285172184802	0.057025978302513915	ELMO1
Parkinson's disease	1/131	0.8899411479214456	0.9235540330048095	0	0	0.4526645041705283	0.05278065600606336	NDUFS7
Cell adhesion molecules (CAMs)	1/133	0.8935993864636472	0.9240266057159937	0	0	0.44576031398320554	0.050147018016435105	SIGLEC1
Tight junction	1/133	0.8935993864636472	0.9240266057159937	0	0	0.44576031398320554	0.050147018016435105	GNAI1
Mitotic G1-G1/S phases	1/135	0.8971363796040438	0.9260244920063206	0	0	0.43906221902535514	0.04765905739060008	TK2
Systemic lupus erythematosus	1/139	0.903862524585448	0.9313012083675062	0	0	0.42624847214946743	0.04308434508326519	FCGR2C
Influenza infection	1/142	0.9086177155472966	0.9339175250857803	0	0	0.41711526958899425	0.03997250174632166	CPSF4
Axon guidance	3/325	0.9096389065826836	0.9339175250857803	0	0	0.5461603613777527	0.05172551747374177	RPS6KA5;RAF1;GNAI1
GPCR ligand binding	4/410	0.9128048705825054	0.9355033931191928	0	0	0.576788896042643	0.05262226474370243	VIPR1;OXER1;F2RL1;TACR1
Signaling by the B cell receptor (BCR)	1/151	0.9215216369504159	0.9424383121654054	0	0	0.3919076305220884	0.032030227359410995	PHLPP1
Integrated breast cancer pathway	1/152	0.9228382086195045	0.9424383121654054	0	0	0.3892922684113939	0.03126069409344507	AHR
Purine metabolism	1/164	0.9370201126266544	0.9552307508579144	0	0	0.3604109690294922	0.023444925294798302	ADCY4
Cell cycle	4/453	0.9458395021824573	0.9611860615400926	0	0	0.5203864040996202	0.028976355451683013	GORASP1;CEP131;TK2;PMF1
Interleukin-2 signaling pathway	9/847	0.9461935579805417	0.9611860615400926	0	0	0.6241381596393529	0.03451991079799468	MX1;ULK2;LCP2;PTPN6;AHR;TNFRSF11A;IFIT1;JAK2;RAF1
Huntington's disease	1/184	0.9551168674790492	0.9685455756334118	0	0	0.3206926064915399	0.014726708511411807	NDUFS7
Lipid and lipoprotein metabolism	4/489	0.9642336749893268	0.9760751411734062	0	0	0.4808573308682982	0.017513599278836674	NEU3;MED8;MED18;PISD
Metabolism	18/1615	0.9768446787668512	0.9871092463195678	0	0	0.6465694605957599	0.015147581879655586	ATP6V1A;PTGES2;MED8;ADCY4;AMT;SAT1;MED18;GNAI1;PISD;NEU3;NDUFS7;B3GALT2;UAP1L1;TBXAS1;CA6;TK2;PIGL;PAOX
Carbohydrate metabolism	1/235	0.9811084516110398	0.9896845744398076	0	0	0.2501415920090619	0.0047707688380740935	PYGM
Class A GPCRs (rhodopsin-like)	1/253	0.9860875812962417	0.9929712642372277	0	0	0.2320591891375024	0.0032511732533328473	F2RL1
FSH regulation of apoptosis	1/263	0.9882634796873893	0.9934286198251283	0	0	0.22308700450657593	0.0026337511076689464	SLC12A6
Protein metabolism	2/442	0.9952337927119327	0.9973136862037978	0	0	0.26403460587750616	0.0012614522279506641	PIGL;GAS6
Signal transduction	8/1020	0.9955852396072573	0.9973136862037978	0	0	0.45375494071146244	0.0020076542645303588	ATP6V1A;LATS2;ADCY4;F2RL1;JAK2;HDAC9;ACVR2B;GNAI1
Signaling by GPCR	7/977	0.9973295719932173	0.9973295719932173	0	0	0.41388590221997346	0.001106730886049407	VIPR1;ADCY4;OXER1;F2RL1;TACR1;RAF1;GNAI1
